Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/science.111.2876.131 | DOI Listing |
Publication Analysis
Top Keywords
kirtley mather
4
mather president
4
president elect
4
elect aaas
4
kirtley
1
president
1
elect
1
aaas
1
Similar Publications
3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance.
ACS Infect Dis
July 2024
VA Portland Healthcare System, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, United States.
ELQ-300 is a potent antimalarial drug with activity against blood, liver, and vector stages of the disease. A prodrug, , exhibits reduced crystallinity and improved in vivo efficacy in preclinical testing, and currently, it is in the developmental pipeline for once-a-week dosing for oral prophylaxis against malaria. Because of the high cost of developing a new drug for human use and the high risk of drug failure, it is prudent to have a back-up plan in place.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!